Pegamotecan

DRUG2 trials

Sponsors

Enzon Pharmaceuticals, Inc.

Conditions

Cancer of StomachGastroesophageal CancerSarcoma, Soft Tissue

Phase 2

Efficacy and Safety Evaluation of Pegamotecan (PEG-camptothecin) in Advanced or Metastatic Soft Tissue Sarcoma

SuspendedNCT00079950

Enzon Pharmaceuticals, Inc.Sarcoma, Soft Tissue

Start: 2003-08-31Updated: 2012-09-06

Efficacy of Pegamotecan (PEG-Camptothecin) in Localized or Metastatic Cancer of the Stomach or Gastroesophageal Junction

TerminatedNCT00080002

Enzon Pharmaceuticals, Inc.Cancer of Stomach, Gastroesophageal Cancer

Start: 2003-12-31Updated: 2012-09-06